[Federal Register Volume 62, Number 38 (Wednesday, February 26, 1997)]
[Notices]
[Pages 8746-8747]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-4736]


-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Cancer Institute; Notice of Meetings

    Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2) notice is hereby given of advisory 
committee meetings of the National Cancer Institute.
    The meetings will be open to the public as indicated below, with 
attendance by the public limited to space available. Individuals who 
plan to attend and need special assistance, such as sign language 
interpretation or other reasonable accommodations, should contact Ms. 
Cynthia Morgan, Committee Management Specialist, at (301) 496-5708 in 
advance of the meetings.
    A portion of the meetings will be closed to the public in 
accordance with the provisions set forth in sections 552b(c)(4), 
552b(c)(6), and 552(c)(9)(B), Title 5, U.S.C. and section 10(d) of 
Public Law 92-463, for the review, discussion and evaluation of 
individual programs and for discussion of issues pertaining to 
programmatic areas and/or NCI personnel. These discussions could reveal 
confidential trade secrets or commercial property such as patentable 
material, and personal information concerning the individuals 
associated with the programs, including consideration of personnel

[[Page 8747]]

qualifications and performance, the competence of individual 
investigators and similar matters, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy and 
premature disclosure of recommendations which would inhibit the final 
outcome and subsequent implementation of recommendations.
    The Committee Management Office, National Cancer Institute, 
National Institutes of Health, Executive Plaza North, Room 630E, 6130 
Executive Boulevard, MSC 7410, Rockville, Maryland 20892-7410, (301) 
496-5708 will provide summaries of the meetings and rosters of the 
committee members, upon request.

    Committee Name: Board of Scientific Counselors, National Cancer 
Institute Basic Sciences Subcommittee B.
    Date: March 2, 1997.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Court, 
Bethesda, MD 20814.
    Closed: 9 p.m. to 10 p.m.
    Agenda: To discuss administrative confidential reports 
pertaining to laboratories in the Division of Basic Sciences.
    Contact Person: Florence Farber, Ph.D., Executive Secretary, 
National Cancer Institute, NIH, Executive Plaza North, Room 643G, 
6130 Executive Boulevard, MSC 7410, Bethesda, MD 20892-7410, (301) 
496-2378.

    Committee Name: Joint Meeting, National Cancer Institute Board 
of Scientific Advisors and Board of Scientific Counselors, National 
Cancer Institute.
    Date: March 3, 1997.
    Place: Conference Room 10, Building 31C, National Institutes of 
Health, 9000 Rockville Pike, Bethesda, MD 20892.
    Open: 8:30 p.m. to 11 a.m.
    Agenda: Report of the Director, NCI; Congressional Update; 
Concept Review.
    Contact Person: Paulette S. Gray, Ph.D., Executive Secretary, 
National Cancer Institute, NIH, Executive Plaza North, Room 600, 
6130 Executive Blvd., MSC 7405, Bethesda, MD 20892-7405, (301) 496-
4218.

    Committee Name: National Cancer Institute Board of Scientific 
Advisors.
    Date: March 3, 1997.
    Place: Conference Room 10, Building 31C, National Institutes of 
Health, 9000 Rockville Pike, Bethesda, MD 20892.
    Open: 11 a.m. to 12:30 p.m.
    Agenda: Discussion of revised cancer centers guidelines and 
present status of paylines.
    Contact Person: Paulette S. Gray, Ph.D., Executive Secretary, 
National Cancer Institute, NIH, Executive Plaza North, Room 600, 
6130 Executive Blvd., MSC 7405, Bethesda, MD 20892-7405, (301) 496-
4218.

    Committee Name: Joint Meeting, Board of Scientific Counselors, 
National Cancer Institute, Clinical Sciences and Epidemiology 
Subcommittee A, Basic Sciences Subcommittee B.
    Date: March 3, 1997.
    Place: Conference Room 6, Building 31C, National Institutes of 
Health, 9000 Rockville Pike, Bethesda, MD 20892.
    Closed: 11:00 am to 12:30 pm.
    Agenda: Discussion of intramural review.
    Contact Person: Robert Hammond, Ph.D., Executive Secretary, 
National Cancer Institute, NIH, Executive Plaza North, Room 643G, 
6130 Executive Boulevard, MSC 7410, Bethesda, MD 20892-7410, (301) 
496-2378.

    Committee Name: Advisory Committee to the Director, National 
Cancer Institute.
    Date: March 3, 1997.
    Place: Conference Room 6, Building 31C, National Institutes of 
Health, 9000 Rockville Pike, Bethesda, MD 20892.
    Open: 12:30 pm to 1:45 pm.
    Agenda: NCI Director's charge to the committee and discussion of 
function and status of various groups reporting their 
recommendations to the committee.
    Contact Person: Susan J. Waldrop, Executive Secretary, National 
Cancer Institute, NIH, Federal Building, Room 312, 7550 Wisconsin 
Avenue, MSC 9010, Bethesda, MD 20892-9010, (301) 496-1458.

    Committee Name: National Cancer Institute Board of Scientific 
Advisors.
    Date: March 3, 1997.
    Place: Conference Room 10, Building 31C, National Institutes of 
Health, 9000 Rockville Pike, Bethesda, MD 20892.
    Open: 12:45 pm to adjournment approximately 6:00 pm.
    Agenda: Integration of BSA and Extramural Divisional interests; 
RFA Concept Reviews.
    Contact Person: Paulette S. Gray, Ph.D., Executive Secretary, 
National Cancer Institute, NIH, Executive Plaza North, Room 600, 
6130 Executive Blvd., MSC 7405, Bethesda, MD 20892-7405, (301) 496-
4218.

    Committee Name: Board of Scientific Counselors, National Cancer 
Institute, Clinical Sciences and Epidemiology Subcommittee A.
    Date: March 3, 1997.
    Place: Conference Room 6, Building 31C, National Institutes of 
Health, 9000 Rockville Pike, Bethesda, MD 20892.
    Closed: 1:45 pm to approximately 3:30 pm.
    Agenda: To discuss administrative confidential reports 
pertaining to laboratories in the Division of Cancer Epidemiology 
and Genetics and the Division of Clinical Sciences.
    Contact Person: Robert Hammond, Ph.D., Executive Secretary, 
National Cancer Institute, NIH, Executive Plaza North, Room 643G, 
6130 Executive Boulevard, MSC 7410, Bethesda, MD 20892-7410, (301) 
496-2378.

    Committee Name: Board of Scientific Counselors, National Cancer 
Institute Basic Sciences Subcommittee B.
    Date: March 3, 1997.
    Place: Conference Room 7, Building 31C, National Institutes of 
Health, 9000 Rockville Pike, Bethesda, MD 20892.
    Closed: 1:45 pm to 6:00 pm.
    Agenda: To discuss administrative confidential site visit 
reports.
    Contact Person: Florence Farber, Ph.D., Executive Secretary, 
National Cancer Institute, NIH, Executive Plaza North, Room 643G, 
6130 Executive Boulevard, MSC 7410, Bethesda, MD 20892-7410, (301) 
496-2378.

    Committee Name: National Cancer Institute Board of Scientific 
Advisors.
    Date: March 4, 1997.
    Place: Conference Room 10, Building 31C, National Institutes of 
Health, 9000 Rockville Pike, Bethesda, MD 20892.
    Open: 8:30 am to adjournment at approximately 12:00 pm.
    Agenda: Status Report: Cancer Control Program Review; RFA 
Concept Reviews.
    Contact Person: Paulette S. Gray, Ph.D., Executive Secretary, 
National Cancer Institute, NIH, Executive Plaza North, Room 600, 
6130 Executive Blvd., MSC 7405, Bethesda, MD 20892-7405, (301) 496-
4218.
    This notice is being published less than 15 days prior to the 
meeting due to the urgent need to meet timing limitations imposed by 
the review and funding cycle and the intramural research review 
cycle.

(Catalog of Federal Domestic Assistance Program Numbers: 93.393, 
Cancer Cause and Prevention Research; 93.394, Cancer Detection and 
Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, 
Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, 
Cancer Research Manpower; 93.399, Cancer Control.)

    Dated: February 21, 1997.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 97-4736 Filed 2-25-97; 8:45 am]
BILLING CODE 4140-01-M